Literature DB >> 7251790

Gas chromatographic determination of the hypoglycaemic agent gliclazide in plasma.

T Maeda, T Yamaguchi, M Hashimoto.   

Abstract

A gas chromatographic method has been developed that permits the accurate and specific determination of the hypoglycaemic agent gliclazide in plasma. Gliclazide is extracted with chloroform and, after clean-up, derivatized with diazomethane followed by heptafluorobutyric anhydride to form N-methyl-N'-heptafluorobutyrylgliclazide, which is assayed on a gas chromatograph equipped with a flame ionization detector, an electron-capture detector or a nitrogen-phosphorus sensitive detector. Accurate determinations are possible with flame ionization detection over a concentration range of 1--15 microgram/ml of gliclazide in plasma with a relative standard deviation of 5.2%. The minimum detectable concentration with electron-capture detection is 0.02 microgram per sample. Plasma levels of gliclazide in dogs following single oral administration (40 mg per dog) have also been determined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251790     DOI: 10.1016/s0378-4347(00)80108-5

Source DB:  PubMed          Journal:  J Chromatogr


  2 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

2.  Development and validation of LC/MS/MS method for the simultaneous determination of montelukast, gliclazide, and nifedipine and its application to a pharmacokinetic study.

Authors:  Essam Ezzeldin; Nisreen F Abo-Talib; Marwa H Tammam; Abdelaaty A Shahat
Journal:  Chem Cent J       Date:  2014-03-11       Impact factor: 4.215

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.